Bionic Power’s purpose is to design and develop lower-body smart orthoses that improve quality of life by enhancing personal mobility and walking abilities.
Bionic Power Inc. is a Canadian, privately held company that has developed and holds IP rights on wearable technology. This technology addresses the rapidly growing market for mobility assistance in patients with knee pathologies.
Our Agilik™ smart orthosis targets patients with crouch gait (due to various conditions such as cerebral palsy, spina bifida, muscular dystrophy and other knee-extension-deficiency disorders) or hemiparesis due to stroke or polio.

Hired in Q3 2021
Former president of Dialco Medical Inc.
23 years in medical devices (clinical development, commercialization, regulatory and manufacturing).

31 years in product development
14 years of gait analysis and exoskeleton design and development experience.
Past experience with Delta Q, Ciena Networks, Nortel

Extensive public and private company CFO experience.
Angela Saunders is an experienced sales leader, executive, and director, with over 12 years of professional service in the Orthotics & Prosthetics industry.
She has extensive insight into developing go-to-market strategies and building strong partner relationships all over the world.
As CEO of Vorum, she brought cutting-edge digital workflow solutions to the custom orthotic and prosthetic field, empowering clinicians to spend more time with their patients.
Angela holds a Bachelor of Commerce and a Bachelor of Biochemistry from Queen’s University.
FABRIZIO BROCCHIERI – DIRECTOR
Fabrizio Brocchieri is an experienced financial advisor and executive with over 25 years of practice in execution and financing of M&A transactions. He has also been chief financial officer and board member of a renewable energy company from the start-up phase until the financial sponsor exit, through the international expansion and strategic re-positioning of the sustainable E-mobility business. Fabrizio spent most of his professional career working for Deutsche Bank Corporate and Investment Banking, Intesa Sanpaolo International Banking Division and he is currently managing director of Capital Insight Partners, an independent financial advisory boutique. Fabrizio graduated from the Università Cattolica del Sacro Cuore, and lives in Milan with his wife and four children.
AARON FLORES – DIRECTOR
Aaron Flores, Ph.D. , currently serves as Vice President of Strategy and Product Development at Hanger, Inc. Aaron has led several organizations in his 14 year tenure at Hanger including Innovative Neurotronics, Surefit, and the Hanger Fabrication Network. Prior to joining Hanger, Aaron worked several years at divisions of Johnson and Johnson leading product development, strategy, and mergers and acquisitions. Aaron holds BS, MS, and PhD degrees in Engineering from the Massachusetts Institute of Technology as well as an MBA from Harvard Business School. He has published research in different fields including O&P and holds several US and international patents.

Dr. Alvarez is a Clinical Professor in the Division of Paediatric Orthopaedic Surgery at the British Columbia Children’s Hospital, University of British Columbia. She has been a faculty member for 22 years and a clinical member/ co-director of the Shriner’s Gait Lab since 2000. Her clinical expertise includes paediatric foot and ankle conditions, Hereditary Multiple Exostosis, spinal cord clinic including congenital and acquired conditions, cerebral palsy, arthrogryposis and gait analysis. She founded and has maintained specialty clinics for HME and complex foot deformities including clubfoot. Dr. Alvarez has been part of impactful committees at the local, national and international level: including the teaching faculty, Advisory Committee for the International Society for Arhrogryposis, Steering Committee for Canadian Botulinum Toxin conference, Orthopaedic Redesign Committee, Trauma Committee and Computer Services Transformation.

Dr. Bulea received his Ph.D. in biomedical engineering from Case Western Reserve University and is a Tenure Track Investigator in the Rehabilitation Medicine Department at the National Institutes of Health in Bethesda, MD. Dr. Bulea’s research focuses on integration of neural interfacing with rehabilitation robotics to develop new therapeutic tools and interventions for treatment of movement disorders and paralysis. Dr. Bulea is the principal investigator on the NIH trial of the Agilik and a co-inventor of the Agilik system.
Dr. Thomas C. Bulea is an employee of the NIH Clinical Center which is part of the National Institutes of Health, an Agency under the US Department of Health and Human Services. Any reference to NIH or to Dr. Bulea should not be viewed as an endorsement of Bionic Power, Inc., its products or services.

Dr. Condliffe’s clinical work and research are driven by an interest in improving clinical interventions to promote neuroplastic change and reduce multisystem impacts of impairments throughout the lifespan of people with cerebral palsy and other causes of long-term neurodisabilities. As a biomedical engineer, neurophysiololgist and physiatrist, she focuses on improving clinical interventions to promote neuroplastic change and reduce multi-system impacts of impairments throughout the lifespan of people. She uses technological innovations including robot-assisted walking, neurophysiologic, biomechanical and clinical tools in assessments, for rehabilitation or as assistive devices. This helps us understand the mechanisms of impairments, deliver targeted interventions, and evaluate them.

Dr. Scher is a Professor of Clinical Orthopaedic Surgery at Weill Cornell Medical College and an Attending Orthopaedic Surgeon in the Division of Pediatric Orthopaedic Surgery at Hospital for Special Surgery in New York City, where he is co-medical director of the Leon Root Motion Analysis Lab.

Dr. Selber is an orthopedic surgeon who has been involved in the treatment of gait and movement disorders in pediatric, adolescent, and adult patients for more than 25 years. He specializes in conditions such as cerebral palsy, spina bifida and several neuromuscular conditions. Early in 2022, Dr. Selber joined HSS where he collaborates with the Dr. Leon Root Motion Analysis Laboratory and continues to care for ambulatory and non-ambulatory children and adults with cerebral palsy.
CONTACT US
SUPPORT
OUR PRIVACY PAGE
© 2024 Bionic Power Inc.
CONTACT US
SUPPORT
OUR PRIVACY PAGE
© 2024 Bionic Power Inc.